| James C Loden, MD | |
|
520 Rivergate Parkway, Goodlettsville, TN 37072-2030 | |
| (615) 859-3937 | |
| (615) 859-3919 |
| Full Name | James C Loden |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 32 Years |
| Location | 520 Rivergate Parkway, Goodlettsville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659330272 | NPI | - | NPPES |
| 3814677 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD0000027224 (Tennessee) | Secondary |
| 207W00000X | Ophthalmology | MD27224 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Loden Vision Center Of Paris, Plc | 0941397244 | 4 |
| James C Loden Md Pc | 3870405244 | 11 |
News Archive
According to a Mayo Clinic obesity researcher, if he had his way sitting at their desks is about the last thing workers would do in his office of the future.
Women with thyroid dysfunction in the first half of pregnancy face an increased risk for gestational diabetes, a form of diabetes that is typically diagnosed during the second trimester, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Anulex Technologies, Inc., a privately held medical device manufacturer, has announced the U.S. Food and Drug Administration (FDA) clearance to market the fiXate Tissue Band product, designed to secure Spinal Cord Stimulation (SCS) lead anchors to the fascia or interspinous/supraspinous ligament in patients with chronic, intractable pain of the trunk and/or limbs.
Using blood, urine and tissue analysis of a unique mouse model, a team led by UC Davis researchers has identified several proteins as diagnostic biomarkers and potential therapeutic targets for kidney cancer. Subject to follow-up validation testing, inhibition of these proteins and several related pathways holds promise as a form of therapy to slow the growth of kidney tumors.
› Verified 7 days ago
| Entity Name | James C Loden Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215077292 PECOS PAC ID: 3870405244 Enrollment ID: O20050714000450 |
News Archive
According to a Mayo Clinic obesity researcher, if he had his way sitting at their desks is about the last thing workers would do in his office of the future.
Women with thyroid dysfunction in the first half of pregnancy face an increased risk for gestational diabetes, a form of diabetes that is typically diagnosed during the second trimester, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Anulex Technologies, Inc., a privately held medical device manufacturer, has announced the U.S. Food and Drug Administration (FDA) clearance to market the fiXate Tissue Band product, designed to secure Spinal Cord Stimulation (SCS) lead anchors to the fascia or interspinous/supraspinous ligament in patients with chronic, intractable pain of the trunk and/or limbs.
Using blood, urine and tissue analysis of a unique mouse model, a team led by UC Davis researchers has identified several proteins as diagnostic biomarkers and potential therapeutic targets for kidney cancer. Subject to follow-up validation testing, inhibition of these proteins and several related pathways holds promise as a form of therapy to slow the growth of kidney tumors.
› Verified 7 days ago
| Entity Name | Loden Vision Center Of Paris, Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457546665 PECOS PAC ID: 0941397244 Enrollment ID: O20071102000536 |
News Archive
According to a Mayo Clinic obesity researcher, if he had his way sitting at their desks is about the last thing workers would do in his office of the future.
Women with thyroid dysfunction in the first half of pregnancy face an increased risk for gestational diabetes, a form of diabetes that is typically diagnosed during the second trimester, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Anulex Technologies, Inc., a privately held medical device manufacturer, has announced the U.S. Food and Drug Administration (FDA) clearance to market the fiXate Tissue Band product, designed to secure Spinal Cord Stimulation (SCS) lead anchors to the fascia or interspinous/supraspinous ligament in patients with chronic, intractable pain of the trunk and/or limbs.
Using blood, urine and tissue analysis of a unique mouse model, a team led by UC Davis researchers has identified several proteins as diagnostic biomarkers and potential therapeutic targets for kidney cancer. Subject to follow-up validation testing, inhibition of these proteins and several related pathways holds promise as a form of therapy to slow the growth of kidney tumors.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James C Loden, MD 520 Rivergate Parkway, Goodlettsville, TN 37072-2030 Ph: (615) 859-3937 | James C Loden, MD 520 Rivergate Parkway, Goodlettsville, TN 37072-2030 Ph: (615) 859-3937 |
News Archive
According to a Mayo Clinic obesity researcher, if he had his way sitting at their desks is about the last thing workers would do in his office of the future.
Women with thyroid dysfunction in the first half of pregnancy face an increased risk for gestational diabetes, a form of diabetes that is typically diagnosed during the second trimester, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Anulex Technologies, Inc., a privately held medical device manufacturer, has announced the U.S. Food and Drug Administration (FDA) clearance to market the fiXate Tissue Band product, designed to secure Spinal Cord Stimulation (SCS) lead anchors to the fascia or interspinous/supraspinous ligament in patients with chronic, intractable pain of the trunk and/or limbs.
Using blood, urine and tissue analysis of a unique mouse model, a team led by UC Davis researchers has identified several proteins as diagnostic biomarkers and potential therapeutic targets for kidney cancer. Subject to follow-up validation testing, inhibition of these proteins and several related pathways holds promise as a form of therapy to slow the growth of kidney tumors.
› Verified 7 days ago
Dr. Terrence J Doherty, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 520 Rivergate Parkway, Goodlettsville, TN 37072 Phone: 615-859-3937 Fax: 615-859-3919 | |
Amish R Purohit, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 520 Rivergate Parkway, Goodlettsville, TN 37072 Phone: 615-859-3937 Fax: 615-859-3919 | |
Dr. Katie Ann Mills, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 520 Rivergate Pkwy, Goodlettsville, TN 37072 Phone: 615-859-3937 Fax: 615-859-3919 |